Literature DB >> 18843192

Surgery and risk of sporadic Creutzfeldt-Jakob disease in Denmark and Sweden: registry-based case-control studies.

Ignacio Mahillo-Fernandez1, Jesús de Pedro-Cuesta, Maria José Bleda, Mabel Cruz, Kåre Mølbak, Henning Laursen, Gerhard Falkenhorst, Pablo Martínez-Martín, Ake Siden.   

Abstract

BACKGROUND: Epidemiologic evidence of surgical transmission of sporadic Creutzfeldt-Jakob disease (sCJD) remains controversial.
METHODS: From Danish and Swedish registries we selected 167 definite and probable sCJD cases (with onset between 1987 and 2003) and 3,059 controls (835 age-, sex-, and residence-matched, and 2,224 unmatched). Independent of case/control status, surgical histories were obtained from National Hospital Discharge Registries. Surgical procedures were categorized by body system group and lag time to onset of sCJD. Exposure frequencies were compared using logistic regression.
RESULTS: A history of any major surgery, conducted >/=20 years before sCJD onset, was more common in cases than both matched (OR = 2.44, 95% CI = 1.46-4.07) and unmatched controls (OR = 2.25, 95% CI = 1.48-3.44). This observation was corroborated by a linear increase in risk per surgical discharge (OR = 1.57, 95% CI = 1.13-2.18; OR = 1.50, 95% CI = 1.18-1.91). Surgery of various body systems, including peripheral vessels, digestive system and spleen, and female genital organs, was significantly associated with increased sCJD risk.
CONCLUSIONS: A variety of major surgical procedures constitute a risk factor for sCJD following an incubation period of many years. A considerable number of sCJD cases may originate from health care-related accidental transmission. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18843192      PMCID: PMC2790765          DOI: 10.1159/000163097

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  33 in total

1.  European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors.

Authors:  I Zerr; J P Brandel; C Masullo; D Wientjens; R de Silva; M Zeidler; E Granieri; S Sampaolo; C van Duijn; N Delasnerie-Lauprêtre; R Will; S Poser
Journal:  J Clin Epidemiol       Date:  2000-07       Impact factor: 6.437

2.  Analysis of the geographical distribution of sporadic Creutzfeldt-Jakob disease in France between 1992 and 1998.

Authors:  Jérôme Huillard D'Aignaux; Simon N Cousens; Nicole Delasnerie-Lauprêtre; Jean-Philippe Brandel; Dominique Salomon; Jean-Louis Laplanche; Jean-Jacques Hauw; Annick Alpérovitch
Journal:  Int J Epidemiol       Date:  2002-04       Impact factor: 7.196

3.  Transmission of prions.

Authors:  C Weissmann; M Enari; P-C Klöhn; D Rossi; E Flechsig
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-14       Impact factor: 11.205

4.  Repeated challenge with prion disease: the risk of infection and impact on incubation period.

Authors:  Mike B Gravenor; Nigel Stallard; Robert Curnow; Angela R McLean
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

5.  Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease.

Authors:  I Zerr; M Pocchiari; S Collins; J P Brandel; J de Pedro Cuesta; R S Knight; H Bernheimer; F Cardone; N Delasnerie-Lauprêtre; N Cuadrado Corrales; A Ladogana; M Bodemer; A Fletcher; T Awan; A Ruiz Bremón; H Budka; J L Laplanche; R G Will; S Poser
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

6.  Transmission of the 263K scrapie strain by the dental route.

Authors:  Loredana Lngrosso; Flavio Pisani; Maurizio Pocchiari
Journal:  J Gen Virol       Date:  1999-11       Impact factor: 3.891

Review 7.  Iatrogenic Creutzfeldt-Jakob disease at the millennium.

Authors:  P Brown; M Preece; J P Brandel; T Sato; L McShane; I Zerr; A Fletcher; R G Will; M Pocchiari; N R Cashman; J H d'Aignaux; L Cervenáková; J Fradkin; L B Schonberger; S J Collins
Journal:  Neurology       Date:  2000-10-24       Impact factor: 9.910

8.  Incidence of Creutzfeldt-Jakob disease in Switzerland.

Authors:  Markus Glatzel; Colette Rogivue; Azra Ghani; Johannes R Streffer; Lorenz Amsler; Adriano Aguzzi
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

9.  Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.

Authors:  C A Llewelyn; P E Hewitt; R S G Knight; K Amar; S Cousens; J Mackenzie; R G Will
Journal:  Lancet       Date:  2004-02-07       Impact factor: 79.321

10.  Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls.

Authors:  H J T Ward; D Everington; E A Croes; A Alperovitch; N Delasnerie-Lauprêtre; I Zerr; S Poser; C M van Duijn
Journal:  Neurology       Date:  2002-08-27       Impact factor: 9.910

View more
  16 in total

1.  Highly sensitive, quantitative cell-based assay for prions adsorbed to solid surfaces.

Authors:  Julie Ann Edgeworth; Graham S Jackson; Anthony R Clarke; Charles Weissmann; John Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-09       Impact factor: 11.205

2.  The prion protein preference of sporadic Creutzfeldt-Jakob disease subtypes.

Authors:  Helen M J Klemm; Jeremy M Welton; Colin L Masters; Genevieve M Klug; Alison Boyd; Andrew F Hill; Steven J Collins; Victoria A Lawson
Journal:  J Biol Chem       Date:  2012-08-28       Impact factor: 5.157

3.  Interventions to reduce the risk of surgically transmitted Creutzfeldt-Jakob disease: a cost-effective modelling review.

Authors:  Matt Stevenson; Lesley Uttley; Jeremy E Oakley; Christopher Carroll; Stephen E Chick; Ruth Wong
Journal:  Health Technol Assess       Date:  2020-02       Impact factor: 4.014

4.  A novel mutation I215V in the PRNP gene associated with Creutzfeldt-Jakob and Alzheimer's diseases in three patients with divergent clinical phenotypes.

Authors:  Mercedes Muñoz-Nieto; Neus Ramonet; Juan Ignacio López-Gastón; Natividad Cuadrado-Corrales; Olga Calero; Marcos Díaz-Hurtado; José Ramón Ipiens; Santiago Ramón y Cajal; Jesús de Pedro-Cuesta; Miguel Calero
Journal:  J Neurol       Date:  2012-07-05       Impact factor: 4.849

5.  Management and prevention of human prion diseases.

Authors:  Silvia Graziano; Maurizio Pocchiari
Journal:  Curr Neurol Neurosci Rep       Date:  2009-11       Impact factor: 5.081

Review 6.  Mammalian prions and their wider relevance in neurodegenerative diseases.

Authors:  John Collinge
Journal:  Nature       Date:  2016-11-10       Impact factor: 49.962

Review 7.  The importance of ongoing international surveillance for Creutzfeldt-Jakob disease.

Authors:  Neil Watson; Jean-Philippe Brandel; Alison Green; Peter Hermann; Anna Ladogana; Terri Lindsay; Janet Mackenzie; Maurizio Pocchiari; Colin Smith; Inga Zerr; Suvankar Pal
Journal:  Nat Rev Neurol       Date:  2021-05-10       Impact factor: 42.937

8.  A standardized comparison of commercially available prion decontamination reagents using the Standard Steel-Binding Assay.

Authors:  Julie Ann Edgeworth; Anita Sicilia; Jackie Linehan; Sebastian Brandner; Graham S Jackson; John Collinge
Journal:  J Gen Virol       Date:  2010-11-17       Impact factor: 3.891

Review 9.  Molecular pathology of human prion disease.

Authors:  Jonathan D F Wadsworth; John Collinge
Journal:  Acta Neuropathol       Date:  2010-08-08       Impact factor: 17.088

10.  Late-in-life surgery associated with Creutzfeldt-Jakob disease: a methodological outline for evidence-based guidance.

Authors:  Mabel Cruz; Ignacio Mahillo-Fernandez; Alberto Rábano; Ake Siden; Miguel Calero; Henning Laursen; Kåre Mølbak; Javier Almazán; Jesus de Pedro-Cuesta
Journal:  Emerg Themes Epidemiol       Date:  2013-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.